e-learning
resources
Virtual 2021
05.09.2021
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cough monitoring during the covid-19 pandemic
J. Smith (Manchester (Greater Manchester), United Kingdom), K. Holt (Manchester (Greater Manchester), United Kingdom), R. Dockry (Manchester (Greater Manchester), United Kingdom), H. Thornton (Ennis, Ireland), F. Keane (Ennis, Ireland), K. Mcguinness (Manchester, United Kingdom)
Source:
Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session:
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session type:
E-poster
Number:
957
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Smith (Manchester (Greater Manchester), United Kingdom), K. Holt (Manchester (Greater Manchester), United Kingdom), R. Dockry (Manchester (Greater Manchester), United Kingdom), H. Thornton (Ennis, Ireland), F. Keane (Ennis, Ireland), K. Mcguinness (Manchester, United Kingdom). Cough monitoring during the covid-19 pandemic. 957
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Preventing the next influenza pandemic
Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning
Year: 2015
Management of respiratory diseases in the COVID-19 pandemic
Source: COVID-19 Videos
Year: 2020
Asthma management and control during COVID-19 pandemic
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Pneumonia and pandemic influenza virus A (H1N1/09). Immediate and remote results
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011
Potential and limits of NIV in pandemic respiratory infections
Source: Annual Congress 2013 –PG11 NIV in growth areas
Year: 2013
The severity of pandemic H1N1 influenza in Albania
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010
A physiological-social score for triaging of pandemic influenza patients
Source: Eur Respir J 2006; 28: Suppl. 50, 631s
Year: 2006
A physiological-social score for triaging of pandemic influenza patients
Source: Eur Respir J 2006; 28: 253-254
Year: 2006
Evaluation of pneumonia cases due to pandemic influenza A (H1N1)
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Early use of oseltamivir protected from respiratory failure in patients with acute flu syndrome during 2009 Brazilian influenza H1N1 pandemics
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Arterial hypoxemia and diminished immune response at admission predict poor outcome in patients with viral-bacterial pneumonia during flu H1N1 pandemic period
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Characteristics and outcome of pneumonia in patients with 2009 pandemic influenza A/H1N1.
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Hospitalizations from pandemic influenza (pH1N1) infections among patients with asthma in Spain
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Influenza activity in Serbia during pandemic
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks
Source: Eur Respir J, 56 (3) 2001400; 10.1183/13993003.01400-2020
Year: 2020
Hospitalizations from pandemic influenza (pH1N1) infections among patients with COPD in Spain
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Sleep disordered breathing management in China during the COVID-19 pandemic
Source: Virtual Congress 2020 – Chinese programme 2020: Part II
Year: 2020
Influenza: from zoonosis to pandemic
Source: ERJ Open Res 2016
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept